Human papillomavirus infection and the primary and secondary prevention of cervical cancer.
about
The structure and regulation of Cullin 2 based E3 ubiquitin ligases and their biological functionsSelf-assembling protein nanoparticles in the design of vaccinesHuman papillomavirus (HPV) screening and cervical cancer burden. A Brazilian perspectiveCutaneous squamous cell carcinoma and human papillomavirus: is there an association?Cancer mortality following radiotherapy for benign gynecologic disordersPrevalence and risk factors for High-Risk Human Papillomavirus (hrHPV) infection among HIV-infected and Uninfected Rwandan women: implications for hrHPV-based screening in Rwanda.HPV infection and cervical disease: a review.Systematic identification of interactions between host cell proteins and E7 oncoproteins from diverse human papillomaviruses.Development of a bead-based multiplex genotyping method for diagnostic characterization of HPV infectionReducing HPV-associated cancer globally.Factors influencing adolescent girls' decision in initiation for human papillomavirus vaccination: a cross-sectional study in Hong Kong.Diagnosis of 25 genotypes of human papillomaviruses for their physical statuses in cervical precancerous/cancerous lesions: a comparison of E2/E6E7 ratio-based vs. multiple E1-L1/E6E7 ratio-based detection techniquesDown-regulation of GRIM-19 expression is associated with hyperactivation of STAT3-induced gene expression and tumor growth in human cervical cancers.U.S. geographic distribution of prevaccine era cervical cancer screening, incidence, stage, and mortalityCervical Cancer Tests and Treatment.Global challenges of implementing human papillomavirus vaccines.Suppression of STAT-1 expression by human papillomaviruses is necessary for differentiation-dependent genome amplification and plasmid maintenance.A quantum dots and superparamagnetic nanoparticle-based method for the detection of HPV DNA.Human papillomavirus type-specific prevalence in women with cervical intraepithelial neoplasm in Western China.Cost-effectiveness of using human papillomavirus 16/18 genotype triage in cervical cancer screening.Age and HPV type as risk factors for HPV persistence after loop excision in patients with high grade cervical lesions: an observational study.Proteomic approaches to the study of papillomavirus-host interactions.Talking about human papillomavirus and cancer: protocol for a patient-centred study to develop scripted consultations.Virus-like particles for the prevention of human papillomavirus-associated malignancies.HPV variants and HLA polymorphisms: the role of variability on the risk of cervical cancer.Novel treatments for head and neck squamous cell carcinoma: preclinical identification and clinical investigation.Vimentin Modulates Infectious Internalization of Human Papillomavirus 16 Pseudovirions.Talking about human papillomavirus and cancer: development of consultation guides through lay and professional stakeholder coproduction using qualitative, quantitative and secondary data.Human papillomavirus in cervical cancer and oropharyngeal cancer: One cause, two diseases.A tailored within-community specimen collection strategy increased uptake of cervical cancer screening in a cross-sectional study in Ghana.Younger age at initiation of the human papillomavirus (HPV) vaccination series is associated with higher rates of on-time completion.A cryo-electron microscopy study identifies the complete H16.V5 epitope and reveals global conformational changes initiated by binding of the neutralizing antibody fragmentMolecular epidemiology of the human papillomavirus infection in self-collected samples from young women.Roles of the PDZ domain-binding motif of the human papillomavirus type 16 E6 on the immortalization and differentiation of primary human foreskin keratinocytes.Optical techniques for cervical neoplasia detection.Epidemiology of cervical human papillomavirus (HPV) infection and squamous intraepithelial lesions (SIL) among a cohort of HIV-infected and uninfected Ghanaian women.What will it take to obtain DNA methylation markers for early cervical cancer detection?The presence of aflatoxin B₁-FAPY adduct and human papilloma virus in cervical smears from cancer patients in Mexico.Multinational comparison of diagnostic clues for uterine cervical lesions among cytotechnologists in Asian countriesPrevention of Cervical Cancer in Sub-Saharan Africa: The Advantages and Challenges of HPV Vaccination
P2860
Q26746044-C91555D7-DF6F-405F-A6D9-F8FED842EDC2Q26767097-BF03EDC1-5261-4DB8-BBAE-A0CC33B3E674Q26799791-83687DF1-03C3-4272-9E54-D9959DBB73ACQ27693832-F4B11F6D-79D8-4DD3-9D4B-020F494AA6FFQ28389787-0885442C-5111-4705-9BB3-7498AA8E696BQ30388952-D52458CE-7DF2-4352-BC05-51CDB47E3B3AQ33159907-8390F146-4BE6-400E-94D8-607EC66F52DEQ34122679-CD4D630C-B399-4F28-AA35-710399FE2C98Q34185819-DB2BCC91-A41B-4092-A92A-0B951E2A9376Q34244580-0B1AD91A-C118-4C0F-9509-A274CD2A418DQ34250662-69A7ADF5-0448-4027-8AEB-590D8C360E38Q34317107-53147D34-14FB-4B86-B89F-06992BD51B30Q34334192-2CF88D52-4BD0-47B2-ACB0-C8DB654DD01DQ34756890-FA36EA98-3FBB-4F59-8615-5DA036E9189DQ35124947-D054D486-1023-4C96-9362-34AC2BE63CA4Q35128768-E4BEB4AA-5FF8-42B5-8B86-419189C0D75CQ35192650-73C8B625-0D65-479A-B677-8073647E09B1Q35537981-0193D4B1-3785-4289-9241-711CDA5134FFQ35806816-77ED956A-62B3-4571-A396-C228393B055FQ36057298-C5AB525C-DBAD-4BE5-976E-6F0AA8067330Q36157210-D4D29CC0-71D6-4F86-B740-26759D57269FQ36468283-B1ABE68D-1CA3-497D-8524-E03EA0E75DBBQ36861147-E643638F-7432-48A6-AF9D-4A949EBA20D2Q37328475-E8EF6EB2-D4F8-456B-8B0B-B33329B447FBQ37448947-9E026209-CC60-4B87-91F8-9125C5298E36Q38221292-CF111FF0-6B4E-4D90-BA90-A5E9481BBA01Q38701705-B33B7E04-34D4-4DF8-A814-8B1270660A2DQ38708079-7EE99C78-6D79-43FB-818D-ACC3EF616621Q39202422-4BEA1E77-4434-453A-B2D0-4F54E4681426Q40099144-B95A9530-9835-4308-AC01-80B9282726EFQ40878643-75959F47-3155-4D29-BF93-15D799E99404Q41606985-E8AB30F1-7BE4-4CE0-B3F2-A983F86411AEQ42248663-A81C6141-F177-4FE3-B653-3569BE2D6A25Q42251888-69D47372-D13C-421C-BF40-C7388A6D85B1Q42371103-AA0A7662-98F1-4A43-AA7B-807FA5BAE167Q42690821-A56288E4-C077-4DC3-97AB-260683CF170FQ43156191-2EE9AD73-E511-496F-A6D3-022E67A5E95BQ43547424-5BEA99A8-923B-417D-BDCD-62BBB970A5A3Q57226440-2E200A72-3A69-49D1-8875-E85955AE7F26Q58196930-AA26D43C-60A2-4A44-B2EE-F6C8C9F99F03
P2860
Human papillomavirus infection and the primary and secondary prevention of cervical cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Human papillomavirus infection ...... prevention of cervical cancer.
@en
Human papillomavirus infection ...... prevention of cervical cancer.
@nl
type
label
Human papillomavirus infection ...... prevention of cervical cancer.
@en
Human papillomavirus infection ...... prevention of cervical cancer.
@nl
prefLabel
Human papillomavirus infection ...... prevention of cervical cancer.
@en
Human papillomavirus infection ...... prevention of cervical cancer.
@nl
P2093
P2860
P356
P1433
P1476
Human papillomavirus infection ...... prevention of cervical cancer
@en
P2093
Allan Hildesheim
Diane Solomon
Douglas R Lowy
John T Schiller
Mark Schiffman
P2860
P304
P356
10.1002/CNCR.23704
P407
P433
P577
2008-10-01T00:00:00Z